Neuroimaging in glioma therapy.

Full Abstract

The introduction of computed tomographic and magnetic resonance imaging into clinical practice is among the most important of all advances in the care of patients with brain tumors. Diffuse astrocytomas of the adult cerebral hemispheres are unique among human tumors for the degree to which their imaging features correlate with pathologic characteristics and clinical behavior. However, there is still little understanding of the value of various imaging features in measuring response and progression in brain tumors. This review focuses on some of the unsolved problems in the use of neuroimaging in measuring the response of brain tumors to therapy.

Author information

Author/s: Henson, John W (JW); Gonzalez, R Gilberto (RG);

Affiliation: Division of Neuroradiology and Brain Tumor Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. henson(-atsign-)helix.mgh.harvard.edu

Journal and publication information

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

Journal: Expert review of neurotherapeutics (Expert Rev Neurother), published in England. (Language: eng)

Reference: 2004-Jul; vol 4 (issue 4) : pp 665-71

Dates: Created 2005/04/27; Completed 2006/04/20; Revised 2006/11/15;

PMID: 15853585, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: 18 Feb 2009 00:00:00)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.